Basit öğe kaydını göster

dc.contributor.authorKONUKOĞLU, Dildar
dc.contributor.authorTABAK, Ömer Fehmi
dc.contributor.authorGEMİCİOĞLU, Bilun
dc.contributor.authorERGİNÖZ, Ethem
dc.contributor.authorERDOĞAN, Mehmet Sarper
dc.contributor.authorACAR, Hazal Cansu
dc.contributor.authorCAN, Gunay
dc.contributor.authorKARAALİ, Rıdvan
dc.contributor.authorBÖREKÇİ, Şermin
dc.contributor.authorBALKAN, İlker İnanç
dc.date.accessioned2021-03-07T01:01:03Z
dc.date.available2021-03-07T01:01:03Z
dc.date.issued2021
dc.identifier.citationACAR H. C. , CAN G., KARAALİ R., BÖREKÇİ Ş., BALKAN İ. İ. , GEMİCİOĞLU B., KONUKOĞLU D., ERGİNÖZ E., ERDOĞAN M. S. , TABAK Ö. F. , "An easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital", BMC INFECTIOUS DISEASES, cilt.21, sa.1, 2021
dc.identifier.issn1471-2334
dc.identifier.otherav_61933a35-5442-46ab-b385-d36ee8bcc9e9
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167402
dc.identifier.urihttps://doi.org/10.1186/s12879-021-05845-x
dc.description.abstractBackgroundOne-fifth of COVID-19 patients are seriously and critically ill cases and have a worse prognosis than non-severe cases. Although there is no specific treatment available for COVID-19, early recognition and supportive treatment may reduce the mortality. The aim of this study is to develop a functional nomogram that can be used by clinicians to estimate the risk of in-hospital mortality in patients hospitalized and treated for COVID-19 disease, and to compare the accuracy of model predictions with previous nomograms.MethodsThis retrospective study enrolled 709 patients who were over 18years old and received inpatient treatment for COVID-19 disease. Multivariable Logistic Regression analysis was performed to assess the possible predictors of a fatal outcome. A nomogram was developed with the possible predictors and total point were calculated.ResultsOf the 709 patients treated for COVID-19, 75 (11%) died and 634 survived. The elder age, certain comorbidities (cancer, heart failure, chronic renal failure), dyspnea, lower levels of oxygen saturation and hematocrit, higher levels of C-reactive protein, aspartate aminotransferase and ferritin were independent risk factors for mortality. The prediction ability of total points was excellent (Area Under Curve=0.922).ConclusionsThe nomogram developed in this study can be used by clinicians as a practical and effective tool in mortality risk estimation. So that with early diagnosis and intervention mortality in COVID-19 patients may be reduced.
dc.language.isoeng
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.subjectImmunology
dc.subjectInfectious Diseases
dc.subjectGeneral Immunology and Microbiology
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectİmmünoloji
dc.subjectBULAŞICI HASTALIKLAR
dc.titleAn easy-to-use nomogram for predicting in-hospital mortality risk in COVID-19: a retrospective cohort study in a university hospital
dc.typeMakale
dc.relation.journalBMC INFECTIOUS DISEASES
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü
dc.identifier.volume21
dc.identifier.issue1
dc.contributor.firstauthorID2528026


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster